What is the best evidence for determining harms of medical treatment?
about
Observational research, randomised trials, and two views of medical scienceCombined oral contraceptives: venous thrombosisVascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancerCombined oral contraceptives: venous thrombosisComparison of pooled risk estimates for adverse effects from different observational study designs: methodological overviewUtilization of inhaled corticosteroids for infants with bronchopulmonary dysplasiaWhat intervention is best practice for vestibular schwannomas? A systematic review of controlled studies.Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?Registration of observational studies: is it time?Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.3-Month Results from Denmark within the Globally Prospective and Observational Study to Evaluate Insulin Detemir Treatment in Type 1 and Type 2 Diabetes: The PREDICTIVE Study.Clinical safety of insulin detemir in patients with Type 2 diabetes in the Gulf countries: The multicenter, noninterventional, open-label LevSafe study.Pharmacological treatment of neonatal seizures: a systematic review.Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries.A pathway to improved prospective observational post-authorization safety studies.The Difficult Airway Society 'ADEPT' guidance on selecting airway devices: the basis of a strategy for equipment evaluation.Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone.A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients.Tailoring treatments using treatment effect modification.Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches.Caring for the older person with chronic obstructive pulmonary disease.Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE).Improved glycemic control with weight loss and a low risk of hypoglycemia with insulin detemir: insights from the Italian cohort of the PREDICTIVE study after 6-month observation in type 2 diabetic subjects.Until RCT proven? On the asymmetry of evidence requirements for risk assessment.Patterns of care in the management of seminoma stage I: results from a European survey.
P2860
Q21144655-423A0683-4327-48FA-8919-17CC4DCD0444Q24198113-108B798C-7B82-4E6B-A8F7-11B031401B9CQ24202199-9473B7F2-8F1C-4A3D-B792-663F197C3404Q24202769-86CFD5E9-FCA5-4337-A767-2537EC58B166Q28535464-FD823FB0-1561-4965-B5C4-0EEEF957BD9DQ28542831-2B602304-6275-4C80-9B97-310DCBD8702EQ30457497-9ED8EB78-3844-4BD8-9C70-33C04A8B7F38Q33503787-F24A8959-F28E-4637-B981-AB28D3CB157FQ33636327-4A1433AB-D09F-46C8-894D-456DFEC3F55EQ33894784-A1A560CE-C1AF-44B2-80D7-7B1640AD3A73Q36084624-6EB63FEB-8856-43A8-A1F0-F919558E1F2CQ37015572-76E59AA3-0403-41E6-83A2-B395AB3B6038Q37249019-6120626D-4900-45AB-BB18-3B7180549959Q37468419-50AE1833-E4AE-4EB0-AEF3-82B389610E0FQ38031932-EC9E80F1-504F-4ADF-9CA2-3654BE4262BEQ38422567-D334F69A-25AA-41B8-A7BF-B71FDF5EA390Q38587979-64365840-7205-41E1-8B51-9E7439A2622DQ38647547-7634E50E-0554-4F0C-A4DC-EBEFE3C35192Q38733650-51D99D40-47EB-46F8-AD6C-A1E1901DE646Q38904292-63561023-6887-4112-998E-05D53FCF88B6Q39241235-2F9FE9DA-68EF-407C-9F71-804B615A6B48Q40012815-FFDA62A3-5E54-46FC-B76B-90E4067ECE25Q42619686-7771ECB4-7E2C-4AC5-9F10-C8E8A6655471Q43753179-9A0B827A-AAE0-48A6-8C92-0726ECA5464BQ48030528-E3EC95FF-38B1-4BA3-832C-3CBBD6A3435F
P2860
What is the best evidence for determining harms of medical treatment?
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
What is the best evidence for determining harms of medical treatment?
@ast
What is the best evidence for determining harms of medical treatment?
@en
What is the best evidence for determining harms of medical treatment?
@nl
type
label
What is the best evidence for determining harms of medical treatment?
@ast
What is the best evidence for determining harms of medical treatment?
@en
What is the best evidence for determining harms of medical treatment?
@nl
prefLabel
What is the best evidence for determining harms of medical treatment?
@ast
What is the best evidence for determining harms of medical treatment?
@en
What is the best evidence for determining harms of medical treatment?
@nl
P2860
P356
P1476
What is the best evidence for determining harms of medical treatment?
@en
P2093
Jan P Vandenbroucke
P2860
P304
P356
10.1503/CMAJ.051484
P407
P577
2006-02-01T00:00:00Z